Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 350748, 9 pages
http://dx.doi.org/10.1155/2010/350748
Research Article

Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection

1Department of Neurosurgery, University of Heidelberg, Heidelberg 69120, Germany
2German Cancer Research Center, Department of Applied Tumor Virology, Heidelberg 69120, Germany
3Department of Gynaecology, University of Tuebingen, Tuebingen 72076, Germany
4Department of Radiation Oncology, HELIOS-Klinikum Berlin, Berlin 13125, Germany

Received 25 March 2009; Revised 6 October 2009; Accepted 19 November 2009

Academic Editor: Daila S. Gridley

Copyright © 2010 Karsten Geletneky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Maher, F. B. Furnari, R. M. Bachoo et al., “Malignant glioma: genetics and biology of a grave matter,” Genes and Development, vol. 15, no. 11, pp. 1311–1333, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. Y. Zhu and L. F. Parada, “The molecular and genetic basis of neurological tumours,” Nature Reviews Cancer, vol. 2, no. 8, pp. 616–626, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. L. M. DeAngelis, “Chemotherapy for brain tumors—a new beginning,” The New England Journal of Medicine, vol. 352, no. 10, pp. 1036–1038, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. E. Combs, J. Debus, and D. Schulz-Ertner, “Radiotherapeutic alternatives for previously irradiated recurrent gliomas,” BMC Cancer, vol. 7, article 167, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. R. Stupp, P.-Y. Dietrich, S. O. Kraljevic et al., “Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide,” Journal of Clinical Oncology, vol. 20, no. 5, pp. 1375–1382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Markert, G. Yancey Gillespie, R. R. Weichselbaum, B. Roizman, and R. J. Whitley, “Genetically engineered HSV in the treatment of glioma: a review,” Reviews in Medical Virology, vol. 10, no. 1, pp. 17–30, 2000. View at Google Scholar · View at Scopus
  7. J. R. Bischoff, D. H. Kirn, A. Williams et al., “An adenovirus mutant that replicates selectively in p53-deficient human tumor cells,” Science, vol. 274, no. 5286, pp. 373–376, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Gromeier, S. Lachmann, M. R. Rosenfeld, P. H. Gutin, and E. Wimmer, “Intergeneric poliovirus recombinants for the treatment of malignant glioma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6803–6808, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Wilcox, W. Yang, D. Senger et al., “Reovirus as an oncolytic agent against experimental human malignant gliomas,” Journal of the National Cancer Institute, vol. 93, no. 12, pp. 903–912, 2001. View at Google Scholar · View at Scopus
  10. D. F. Stojdl, B. Lichty, S. Knowles et al., “Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus,” Nature Medicine, vol. 6, no. 7, pp. 821–825, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. Allen, G. Paraskevakou, C. Liu et al., “Oncolytic measles virus strains in the treatment of gliomas,” Expert Opinion on Biological Therapy, vol. 8, no. 2, pp. 213–220, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. Y. C. M. Herrero, J. J. Cornelis, C. Herold-Mende, J. Rommelaere, J. R. Schlehofer, and K. Geletneky, “Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing,” International Journal of Cancer, vol. 109, no. 1, pp. 76–84, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. Di Piazza, C. Mader, K. Geletneky et al., “Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells,” Journal of Virology, vol. 81, no. 8, pp. 4186–4198, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. Rommelaere and J. J. Cornelis, “Autonomous parvoviruses,” in Replication-Competent Viruses for Cancer Therapy, D. P. Hernaiz and S. D. Rabkin, Eds., vol. 22 of Monographs in Virology, pp. 100–129, Karger, Basel, Switzerland, 2001. View at Google Scholar
  15. N. Laperriere, L. Zuraw, and G. Cairncross, “Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review,” Radiotherapy and Oncology, vol. 64, no. 3, pp. 259–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Aghi and R. L. Martuza, “Oncolytic viral therapies—the clinical experience,” Oncogene, vol. 24, no. 52, pp. 7802–7816, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. S. J. Advani, J. J. Mezhir, B. Roizman, and R. R. Weichselbaum, “ReVOLT: radiation-enhanced viral oncolytic therapy,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 3, pp. 637–646, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. J. Advani, G. S. Sibley, P. Y. Song et al., “Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors,” Gene Therapy, vol. 5, no. 2, pp. 160–165, 1998. View at Google Scholar · View at Scopus
  19. R. L. Chu, D. E. Post, F. R. Khuri, and E. G. Van Meir, “Use of replicating oncolytic adenoviruses in combination therapy for cancer,” Clinical Cancer Research, vol. 10, no. 16, pp. 5299–5312, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Twigger, L. Vidal, C. L. White et al., “Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy,” Clinical Cancer Research, vol. 14, no. 3, pp. 912–923, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. C. Liu, J. N. Sarkaria, C. A. Petell et al., “Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme,” Clinical Cancer Research, vol. 13, no. 23, pp. 7155–7165, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S. Faisst, S. R. Faisst, T. Dupressoir et al., “Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells,” Journal of Virology, vol. 69, no. 7, pp. 4538–4543, 1995. View at Google Scholar · View at Scopus
  23. M. H. Fox, “A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry,” Cytometry, vol. 1, no. 1, pp. 71–77, 1980. View at Google Scholar · View at Scopus
  24. M. Zeng, G. J. Cerniglia, S. L. Eck, and C. W. Stevens, “High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation,” Human Gene Therapy, vol. 8, no. 9, pp. 1025–1032, 1997. View at Google Scholar · View at Scopus
  25. S. Wolter, R. Richards, and R. W. Armentrout, “Cell cycle-dependent replication of the DNA of minute virus of mice, a parvovirus,” Biochimica et Biophysica Acta, vol. 607, no. 3, pp. 420–431, 1980. View at Google Scholar · View at Scopus
  26. S. Bao, Q. Wu, R. E. McLendon et al., “Glioma stem cells promote radioresistance by preferential activation of the DNA damage response,” Nature, vol. 444, no. 7120, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus